osteoarthritis of the hip

From Aaushi
Jump to navigation Jump to search

Genetics

familial predisposition[2]

Clinical manifestations

* hip flexion is the most important action when climbing

Radiology

Complications

  • fatigue is the strongest risk factor for reduced activity[14]

Differential diagnosis

Management

More general terms

Additional terms

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 Medical Knowledge Self Assessment Program (MKSAP) 11,14,16,17, 19 American College of Physicians, Philadelphia 1998,2006,2012,2015, 2022
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  2. 2.0 2.1 Journal Watch 21(2):15, 2001 Lanyon P et al, Assessment of a genetic contribution to osteoarthritis of the hip: sibling study. BMJ 321:1179, 2000 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11073507
  3. 3.0 3.1 Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2007 Jul;56(7):2278-87. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17599747
  4. Atchia I, Kane D, Reed MR, Isaacs JD, Birrell F. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis. 2011 Jan;70(1):110-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21068096
  5. Prieto-Alhambra D, Javaid MK, Judge A, Maskell J et al Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum. 2011 Apr;63(4):992-1001. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21452321
  6. 6.0 6.1 Ravi B et al The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis: propensity score matched landmark analysis. BMJ 2013;347:f6187 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24174640 <Internet> http://www.bmj.com/content/347/bmj.f6187
  7. Zhang W, Moskowitz RW, Nuki G et al OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007 Sep;15(9):981-1000. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17719803
    Zhang W, Moskowitz RW, Nuki G et al OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008 Feb;16(2):137-62. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18279766
    Zhang W, Nuki G, Moskowitz RW et al OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010 Apr;18(4):476-99. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20170770
  8. Hochberg MC, Altman RD, April KT et al American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22563589 (corresponding NGC guideline withdrawn Dec 2017)
  9. 9.0 9.1 Bennell KL et al Effect of Physical Therapy on Pain and Function in Patients With Hip Osteoarthritis. A Randomized Clinical Trial. JAMA. 2014;311(19):1987-1997 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24846036 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1872817
  10. Fernandes L, Hagen KB, Bijlsma JW EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis. 2013 Jul;72(7):1125-35 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23595142
  11. 11.0 11.1 Kim C et al Association of hip pain with radiographic evidence of hip osteoarthritis: diagnostic test study. BMJ 2015;351:h5983 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/2663129 <Internet> http://www.bmj.com/content/351/bmj.h5983
    Nieuwenhuijse M, Nelissen R Hip pain and radiographic signs of osteoarthritis. BMJ 2015;351:h6262 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26635241 <Internet> http://www.bmj.com/content/351/bmj.h6262
  12. 12.0 12.1 Allen KD, Yancy YS. Bosworth HB et al A Combined Patient and Provider Intervention for Management of Osteoarthritis in Veterans: A Randomized Clinical Trial. Ann Intern Med. Published online 22 December 2015 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26720751
    Allen KD, Oddone EZ, Coffman CJ et al. Patient, provider, and combined interventions for managing osteoarthritis in primary care: A cluster randomized trial. Ann Intern Med 2017 Jan 17 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28114648 <Internet> http://annals.org/article.aspx?articleid=2478159
  13. 13.0 13.1 da Costa BR, Reichenbach S, Keller N et al Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. March 17, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26997557 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2816%2930002-2/abstract
    Moore N, Salvo F, Duong M, Gulmez SE Does paracetamol still have a future in osteoarthritis? Lancet. March 17, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26997558 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2901170-8/abstract
  14. 14.0 14.1 14.2 Geriatric Review Syllabus, 9th edition (GRS9) Medinal-Walpole A, Pacala JT, Porter JF (eds) American Geriatrics Society, 2016
    Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
  15. Brown MD, Gomez-Marin O, Brookfield KF, Li PS. Differential diagnosis of hip disease versus spine disease. Clin Orthop Relat Res. 2004 Feb;(419):280-4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15021166
  16. 16.0 16.1 Valdes AM, Abhishek A, Muir K et al Association of Beta-Blocker Use With Less Prevalent Joint Pain and Lower Opioid Requirement in People With Osteoarthritis. Arthritis Care Res (Hoboken). 2017 Jul;69(7):1076-1081. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27696728
  17. 17.0 17.1 17.2 Dorleijn DMJ, Luijsterburg PAJ, Reijman M et al. Intramuscular glucocorticoid injection versus placebo injection in hip osteoarthritis: A 12-week blinded randomised controlled trial. Ann Rheum Dis 2018 Jun; 77:875 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29514801 <Internet> http://ard.bmj.com/content/77/6/875
  18. 18.0 18.1 18.2 Okike K, King RK, Merchant JC et al. Rapidly destructive hip disease following intra-articular corticosteroid injection of the hip. J Bone Joint Surg Am 2021 Nov 17; 103:2070. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34550909 https://journals.lww.com/jbjsjournal/Abstract/2021/11170/Rapidly_Destructive_Hip_Disease_Following.2.aspx
  19. 19.0 19.1 Paskins Z et al. Clinical effectiveness of one ultrasound guided intra-articular corticosteroid and local anaesthetic injection in addition to advice and education for hip osteoarthritis (HIT trial): Single blind, parallel group, three arm, randomised controlled trial. BMJ 2022 Apr 6; 377:e068446. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35387783 Free article https://www.bmj.com/content/377/bmj-2021-068446.long
  20. 20.0 20.1 van den Driest JJ et al. No added value of duloxetine in patients with chronic pain due to hip or knee osteoarthritis: A cluster-randomized trial. Arthritis Rheumatol 2022 May; 74:818 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34989159 https://onlinelibrary.wiley.com/doi/10.1002/acr.24519
    Lenhard NK et al. Does screening for depressive symptoms help optimize duloxetine use in knee osteoarthritis patients with moderate pain? A cost-effectiveness analysis. Arthritis Rheumatol 2022 May; 74:776 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33253496 PMCID: PMC8164641 (available on 2023-05-01) https://onlinelibrary.wiley.com/doi/10.1002/acr.24519
  21. 21.0 21.1 Zhang X et al. Efficacy and safety of tramadol for knee or hip osteoarthritis: A systematic review and network meta-analysis of randomized controlled trials. Arthritis Care Res (Hoboken) 2023 Jan; 75:158. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34251756 https://onlinelibrary.wiley.com/doi/10.1002/acr.24750
  22. 22.0 22.1 Joseph GB et al. Effects of weight change on knee and hip radiographic measurements and pain over four years: Data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2023 Apr; 75:860. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35245415 PMCID: PMC9440955 (available on 2024-04-01) https://onlinelibrary.wiley.com/doi/10.1002/acr.24875
    Salis Z et al. Investigation of the association of weight loss with radiographic hip osteoarthritis in older community-dwelling female adults. J Am Geriatr Soc 2023 Aug; 71:2451 PMID: https://www.ncbi.nlm.nih.gov/pubmed/37074126 https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.18371
  23. 23.0 23.1 Heijman MWJ et al. Association of low-dose colchicine with incidence of knee and hip replacements: Exploratory analyses from a randomized, controlled, double-blind trial. Ann Intern Med 2023 May 30; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/37247416 https://www.acpjournals.org/doi/10.7326/M23-0289
  24. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72:220-233. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31908163

Patient information

osteoarthritis of the hip patient information